| Literature DB >> 12207001 |
Frank Rose1, Friedrich Grimminger, Jutta Appel, Mathias Heller, Volker Pies, Norbert Weissmann, Ludger Fink, Sebastian Schmidt, Stefanie Krick, Gieri Camenisch, Max Gassmann, Werner Seeger, Jörg Hänze.
Abstract
Chronic lung hypoxia causes vascular remodeling with pulmonary artery smooth muscle cell (SMCPA) hyperplasia, resulting in pulmonary hypertension and cor pulmonale. We investigated SMCPA and pulmonary artery adventitial fibroblasts (FBPA) for their proliferative response to hypoxia. Strong SMCPA growth occurred under hypoxic conditions in SMCPA/FBPA co-cultures, but not in SMCPA monocultures. SMCPA growth was fully reproduced by transferring serum-free supernatant from hypoxic cultured FBPA to normoxic SMCPA. Hypoxia-inducible-transcription-factor subtypes (HIF-1alpha, HIF-2alpha, HIF-3alpha) and its dependent target genes, carrying the hypoxia-responsive-element as regulatory component, were strongly activated in both hypoxic FBPA and SMCPA. HIF-transcription-factor decoy technique, employed to FBPA during hypoxic culturing, blocked the mitogenic activity of FBPA conditioned medium on SMCPA. The data suggest that hypoxia-driven gene regulation in pulmonary artery fibroblasts results in a mitogenic stimulus on adjacent pulmonary artery smooth muscle cells, and HIF-transcription-decoy may offer a new therapeutic approach to suppress these events.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12207001 DOI: 10.1096/fj.02-0420fje
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191